PBA
Paradigm Biocapital Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-944,917
| Closed | -$14.9M | – | 42 |
|
|
2024
Q1 | $14.9M | Buy |
944,917
+544,917
| +136% | +$8.59M | 0.52% | 30 |
|
|
2023
Q4 | $6.06M | Buy |
+400,000
| New | +$6.06M | 0.28% | 28 |
|
|
2022
Q2 | – | Sell |
-287,577
| Closed | -$13.3M | – | 28 |
|
|
2022
Q1 | $13.3M | Sell |
287,577
-12,857
| -4% | -$593K | 3.51% | 13 |
|
|
2021
Q4 | $25.3M | Buy |
+300,434
| New | +$25.3M | 7.21% | 3 |
|